Wealthcare Capital Management LLC Biogen Inc. Transaction History

Wealthcare Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3,626 - $5,805	-14 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$242.95 - $284.63 $3,401 - $3,984	14 New	14 $4,000
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $3,763 - $4,774	-14 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$220.06 - $304.07 $3,080 - $4,256	14 New	14 $4,000
Q2 2017 Aug 22, 2017	SELL	N/A	-9 Closed	0 $0
Q1 2016 Sep 20, 2017	BUY	N/A	9	9 $2,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wealthcare Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Capital Management LLC with notifications on news.